Literature DB >> 16449759

Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.

Hideaki Matsui1, Fukashi Udaka, Akiko Tamura, Masaya Oda, Tamotsu Kubori, Kazuto Nishinaka, Masakuni Kameyama.   

Abstract

Pathophysiology of hallucinations in Parkinson's disease is poorly understood. This study investigated relationships between visual hallucinations and visual acuity. Twenty-six consecutive patients with Parkinson's disease participated in this study. Patients were divided into two groups: patients with visual hallucinations (VH group) and those without visual hallucinations (no-VH group). Unaided and corrected eyesight was evaluated in all patients, and if frequent use of prescription glasses or contact lenses was involved, eyesight using these lenses was also measured as the patient's own best eyesight. If a patient did not use prescription glasses or contact lenses, the patient's own best eyesight was defined as the unaided eyesight. Multivariate regression analysis demonstrated that agonist use and best eyesight were different after the backward elimination method. Visual hallucinations were closely related not to uncorrected eyesight or unaided eyesight but to the patient's best eyesight. It is suggested that impaired visual acuity is a risk factor for visual hallucinations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449759     DOI: 10.1177/0891988705284739

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  21 in total

1.  Self-reported vision and hallucinations in older adults: results from two longitudinal US health surveys.

Authors:  Ali G Hamedani; Dylan P Thibault; Judy A Shea; Allison W Willis
Journal:  Age Ageing       Date:  2020-08-24       Impact factor: 10.668

Review 2.  Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.

Authors:  Niyatee Samudra; Neepa Patel; Kyle B Womack; Pravin Khemani; Shilpa Chitnis
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

3.  Retina as a Model to Study In Vivo Transmission of α-Synuclein in the A53T Mouse Model of Parkinson's Disease.

Authors:  Najiba Mammadova; Thierry Baron; Jérémy Verchère; Justin J Greenlee; M Heather West Greenlee
Journal:  Methods Mol Biol       Date:  2021

4.  Psychometric Properties and Characteristics of the North-East Visual Hallucinations Interview in Parkinson's Disease.

Authors:  Kelsey A Holiday; Eva Pirogovsky-Turk; Vanessa L Malcarne; J Vincent Filoteo; Irene Litvan; Stephanie L Lessig; David Song; Dawn M Schiehser
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

Review 5.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

Review 6.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

Review 7.  Treatment of Visual Disorders in Parkinson Disease.

Authors:  Joseph Savitt; Michaela Mathews
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

Review 8.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

9.  Face pareidolia is associated with right striatal dysfunction in drug-naïve patients with Parkinson's disease.

Authors:  Hidetomo Murakami; Tomotaka Shiraishi; Tadashi Umehara; Shusaku Omoto; Maki Takahashi; Haruhiko Motegi; Takahiro Maku; Takeo Sato; Hiroki Takatsu; Teppei Komatsu; Keiko Bono; Kenichiro Sakai; Hidetaka Mitsumura; Yasuyuki Iguchi
Journal:  Neurol Sci       Date:  2021-04-22       Impact factor: 3.307

10.  Visual symptoms in Parkinson's disease.

Authors:  R A Armstrong
Journal:  Parkinsons Dis       Date:  2011-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.